PolarisAR appoints Andy Menon to its Board of Directors

– USA, FL –  PolarisAR, a developer of advanced mixed-reality surgical guidance technology, announced the appointment of Andy Menon to its board of directors.

About Aravind Menon

Andy Menon serves as senior associate general counsel for Nasdaq, where he played a significant role in ensuring regulatory compliance and overseeing legal matters related to the operations of Nasdaq’s futures exchange. Before his time at Nasdaq, he held key positions at Deutsche Bank and the U.S. Commodity Futures Trading Commission, where he gained deep insights into regulatory affairs and government relations.

Andy Menon received his Bachelor of Arts in Psychology from Hartwick College, a Juris Doctor from Albany Law School, and a Master of Laws specializing in Securities & Financial Regulation from Georgetown University Law Center.

About PolarisAR

PolarisAR is a privately held startup based in Miami, founded in 2020. The company is developing a new class of mixed-reality surgical technology designed to optimize intraoperative workflows and improve patient outcomes using advanced, three-dimensional spatial computing algorithms. Its first product is the STELLAR Knee mixed-reality surgical guidance system, cleared by the FDA in 2023 for total knee arthroplasty (TKA) procedures. STELLAR Knee offers a mixed-reality platform that comprehensively assesses bony anatomy and soft tissue to ensure precise extension and flexion gap resections. By combining the benefits of robot-like precision with the simplicity of a mixed-reality headset, Polaris aims to transform the landscape of orthopedic surgery.

For more information: https://thinkpolaris.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.